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Abstract
Background: Quality of life has become an important concept in cancer care. Among the quality of lifestudies in
cancer patients, breast cancer has received most attention. This review reports on quality of life in Arab patients
with breast cancer.
Methods: The search was conducted using inclusion and exclusion criteria and in accordance with Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The databases consulted were PubMed,
Sciences Direct, Index Medicus for Wordl Health Organization Eastern Mediterranean, African Journals Online and
African Index Medicus.
Results: Thirteen articles from eight countries met the inclusion criteria. The EORTC quality of life questionnaires
(QLQ-C30 and QLQ-BR23) were the most used instrument (7 out of 13). The results showed that good scores of
global health were recorded at Arab women living in United Arab Emirates (mean score = 74.6) compared to other
countries. The results indicated that there was a difference in quality of life scores and its associated factors among
Arab women with breast cancer.
Conclusion: This paper is the first that reviewed published research on quality of life among Arab women with
breast cancer. We found that insufficient results-related information is available.
Keywords: Quality of life, Breast cancer, Arab women
Background
Quality of life (QOL) has become an important outcome
measure in the treatment of cancer patients during the
last decade. It is a multidimensional construct encom-
passing perceptions of both positive and negative aspects
of dimensions such as physical, emotional, social and
cognitive functions, as well as the negative aspects of
somatic discomfort and other symptoms produced by a
disease or its treatment [1]. Clinical trials have shown
that changes in QOL are associated with changes in clin-
ical variables including survival [2].
It has been shown that assessing QOL in cancer pa-
tients could contribute to improve treatment and could
be an important prognostic factor [3–6].
Among the QOL studies in cancer patients, breast
cancer has received most attention. This is partly due to
the increasing number of patients. Statistics show that
breast cancer is by far the most frequent cancer among
women in the world, with an estimated 1,67 million new
cases diagnosed in 2012 [7]. On the other hand, through
early detection programs and more effective treatments,
more women with breast cancer are surviving longer [8].
However, the physical, functional, psychological and
social difficulties of the women treated for cancer can
compromise their QOL. The QOL studies in breast can-
cer patients reported that anxiety, depression, pain, fa-
tigue, and arm morbidity were the most reported
symptoms [9].
Patients receiving chemotherapy might experience sev-
eral side-effects and symptoms that negatively affect
their QOL [9] and patients who underwent mastectomy
indicated lower body image and sexual functioning than
those who did not [9].
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Many psychosocial and medical factors, like age, pa-
tient education, spousal support and employment status,
financial stability, disease stage, have been reported in
the literature to predict the QOL of patients [1, 10].
The Arab world has a total of 22 countries spread
across Northern Africa and Western Asia, including the
Middle East. Data from Arab countries on breast cancer
vary according to region and country. In Arab countries,
the breast cancer represents 14 % to 42 % of all female
cancers [11]. Age-adjusted standardized incidence rates
(ASR) were reported to vary from 9.5 to 50 cases per
100,000 women per year [11]. 50 % of cases are younger
than 50 years compared to 25 % in developed countries
[11]. Cancer remains a taboo in most Arab countries
[11]. The majority of people still refer to it as “other dis-
ease” and remain afraid of mentioning it by name [11].
Arab womenshare a set of different cultural, norms and
beliefs and studies have shown that patient-based out-
comes could be affected by cultural experiences and eth-
nic backgrounds [12, 13].
Analysis of a large international database of the
European Organization for Research and Treatment in
Cancer Quality of Life Questionnaire (EORTCQLQ–
C30) indicated that,compared with patients from the
United Kingdom; physical and social functioning were
less important in predicting the global QOL of pa-
tients from Islamic countries, while cognitive func-
tioning was more influential for South Asia and Latin
America [14].
Recently, healthcare providers in Arab countries have
started looking at the QOL of women diagnosed and liv-
ing with breast cancer and the QOL is receiving more
and more attention from researchers. The aim of the
present review is to collect and examine publication that
have appeared in English and French biomedical jour-
nals. The findings will constitute an evidence base for
the cancer control programs in Arab countries and may
reveal findings that will ultimately require a specific ap-
proaches for assisting Arab patients according to the
specificities of their culture and religion.
Methods
Search strategy
The search was conducted to identify studies reporting
the QOL in Arab women with breast cancer in accordance
with Preferred Reporting Items for Systematic Reviews
and Meta-Analyses statement criteria (PRISMA) [15].
A systematic literature search was conducted using
PubMed, Sciences direct,Index Medicus for World
Health Organization (WHO) Eastern Mediterranean,
African Journals Online and African Index Medicus
(AIM). The reference lists of all identified publications
were checked to retrieve other relevant publications,
which were not identified through of the computerised
search. until May 2015, without restrictions of language
or year of publication.
We use the term quality of life to be synonymous with
the expression health-related quality of life.
The search strategy included the following keywords
or their combinations in titles of publications:quality of
life, health related quality of life, breast cancer, breast
carcinoma, North Africa, Middle East, Arabic countries,
Morocco, Algeria, Tunisia, Libya, Mauritania, Oman,
Saudi Arabia, Bahrain, Comoros, Djibouti, Egypt, United
Arab Emirates, Iraq, Jordan, Kuwait, Lebanon, Palestine,
Qatar, Somalia, Sudan, Syria, Yemen.
Inclusion and exclusion criteria
Studies were included if they described aspects of the
quality of life or health quality of life in Arab women
with breast cancer, and presented the results on the
quality of life evencross- cultural adaptation studies.
We excluded studies that did not pertain Arab women
or reported on all types of cancers and did not specify
the breast cancer. Furthermore, we excluded studies and
information published only as abstracts.
Type of studies
Were included both qualitative and quantitative studies
in this review. For the quantitative studies, both observa-
tional and interventional were included.
Analyzed outcomes
The analyzed outcomes were global QOL score, QOL
domains, factors associated with QOL, perceptions and
attitudes.
Results
Our findings indicate that studies on QOL in Arab
women with breast cancer are very scarce. Indeed, among
the 22 Arab countries, only 09 have conducted studies in
this field (Fig. 1).
Figure 2 shows the flowchart of the systematic review
process followed. The initial search identified a total of
590papers; among them 570 manuscriptswere excluded
due to duplication. Twenty potential articles were identified
based on the relevance of the abstracts. Followinga thor-
ough review of the full text,thirteen articles were eligible for
inclusion.
Characteristics of included studies
Thirteen studies met the inclusion criteria. All were
published between 1997 and 2014. The first study was
conducted in 1997 while the second until 2008. The other
eleven studies all published in the last six years. The qual-
ity assessment of selected studies are shown in Table 1.
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A total of 4132 Arab women with breast cancer were
studied in these investigations. Characteristics of the
studies are shown in Table 2.
Objectives and study design
In the Thirteen studies, only one study was qualitative
[16] and the remaining twelve were quantitative stud-
ies [17–28]. Among the quantitative studies, one was
an interventional study [21] and eleven were cross-
sectional studies [17–19], [22–28].
Two of the studies reported validation or cultural
adaptation of QOL questionnaires [18, 27]. Ten arti-
cles focused on the impact of breast cancer and its
treatment on QOL of women with breast cancer and
analyzed the influence of sociodemographic and clin-
ical data [17], [19–26], [28]. The interventional study
conducted in Egypt aimed to improve the QOL of af-
fected patients and their families. The intervention
was conducted through communication by phone
calls, health education messages, restorative (rehabili-
tative) therapy for needed cases, social and financial
Fig. 1 Results of the literature search made for each Arabic country
Fig. 2 Flow chart of process of systematic literature search in accordance with PRISMA
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El Sharkawi et al. [17] Yes Yes Yes No Yes Yes Yes Yes Yes Yes
Awad et al. [18] Yes Yes Yes No Yes Yes Yes Yes Yes (just for breast
cancer patients)
Yes
Alawadi and Ohaeri [19] Yes Yes Yes No Yes Yes Yes Yes Yes Yes
Masmoudi et al. [20] Yes Yes Yes No Yes Yes Yes Yes Yes Yes
Mostafa et al. [21] Yes Yes Yes No ND Yes Yes Yes Yes No (type II)
Al-Naggar et al. [22] Yes Yes Yes No Yes Yes Yes Yes Yes Yes
Huijer and Abboud [23] Yes Yes Yes No Yes Yes Yes Yes Yes Yes
Denewer et al. [24] Yes Yes Yes No ND Yes Yes Yes Yes Yes
Ba-Khubaira and Al-Kahiry [25] Yes Yes Yes No Yes Yes Yes Yes Yes Yes
Jassim and Whitford [26] Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Jassim and Whitford [16] Yes Yes Yes No Yes Yes ND (qualitative
study)
Yes Yes Yes
El Fakir et al. [27] Yes Yes Yes No Yes Yes Yes Yes Yes (not for other
regional languages)
Yes




















Table 2 Characteristics of included studies
Author/Year/Reference Country and setting Study design and
Population
Main focus QOL Assessment Outcome Comparison Main finding and
effects
El Sharkawi et al. [17] Egypt
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Awad et al. [18] United Arab Emirates
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Table 2 Characteristics of included studies (Continued)

















Participants had a mean
score for global QOL of
72.5 pre chemo
And 68.5 during chemo.
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Mostafa et al. [21] Egypt
El- Minia oncology center
Interventional hospital





















38.3 % of studied females
had poor global health
status/QOL
52.8 % had good global
health status/QOL
There is a significant
change in physical, role,
emotional, cognitive and
social functioning in pre-
and post-intervention
assessment.
180 female breast cancer
patients in pre-intervention
75 patients (with global
health status/QOL score
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Table 2 Characteristics of included studies (Continued)



























reconstruction had a high
mean score of BSS: 14.44
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No difference was found
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58 Yemeni patients with
early stage breast cancer.
During follow-up for the













The overall QOL reported
in this study among breast
cancer Yemeni patients in
Aden was 77.6 and the
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Yemeni patients with
early breast cancer are
having lower QOL after
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score for global QOL of
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being able to perform
every day chores and the
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daily role as a woman,
wife, daughter and
employee
Hair loss was a major side
effect of treatment the



























Table 2 Characteristics of included studies (Continued)
important role played by
the family and husband
in treatment decisions
the use of traditional
clothing (hijab and abaya)
to hide hair and body
changes
the importance of
spirituality and religion to
cope with the disease
El Fakir et al. [27] Morocco
National institute of
oncology in Rabat and
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support [21]. The qualitative study conducted in
Bahrain explored the experiences, beliefs, perceptions
and attitudes of women with breast cancer towards
their QOL [16].
Questionnaires
The EORTC questionnaires were used in seven studies.
Three of them used only the QLQ-C30 [20, 23, 26], four
used both The EORTC QLQ – C30 and theEORTC-
breast cancer- specific quality of life questionnaire
(EORTCQLQ-BR23) [18, 19, 21, 28] and one study used
only the specific module for breast cancer the QLQ-
BR23 [27]. The studies conducted in Yemen have used
the Functional Assessment of Cancer Therapy- Breast
(FACT-B) questionnaire to assess the QOL [22, 25].
Other questionnaires were used in two studies con-
ducted in Egypt namely the Breast Impact of Treatment
Scale (BITS) [24] and Linear Analogue Self-Assessment
Scales (LASA) [17].
Global quality of life
Concerning studies using the QLQ-C30, good scores of glo-
bal QOL were recorded for Arab women living in United
Arab Emirates (UAE) and also for Tunisian, Bahraini and
Jordanian women with mean score of 74.6,68.5, 63.9, 63.7
respectively [18, 20, 26, 28]. The score obtained for Leba-
nese [23] was 59.64 while the Kuwaiti women [19] had
lower score (45.30).
The first QOL study conducted among Arab women
was in Egypt in 1997 has used a LASA and the results
were focused on the impact of the modality of treatment
on the QOL [17]. The study conducted by Mostafa et al.
shown that 38.3 % of Egyptian patients had poor global
QOL and 52.8 % had good global QOL [21]. Another
study conducted also in Egypt used the BITS and Body
Satisfaction scale (BSS) but has not given any scores of
QOL [24]. The study conducted in Yemen used FACT-B
and reported 77.6 as overall QOL [25].
Functioning and Symptoms
According to the EORTC QLQ-C30 and the EORTC BR-
23 scores, Arab patients with breast cancer have an average
to intense symptoms experience. Within the functional
scales, the worst scores were for emotional functioning,
body image and future perspective [19, 23, 26, 28].
In Kuwait, findings showed that patients were optimis-
tic about their future health. The best domains of QOL
were cognitive, social and sexual functioning. Domains
with low scores were general wellbeing and physical
functioning. Intense level of symptom experience was
hair loss [19]. High scores were reported on functional
ability, medical care, spirituality, and relationships for
Lebanese women with breast cancer and the most com-
mon symptoms were nervousness, sadness, lack of
energy and pain [23]. Among Bahraini patients, social
functioning scored the highest, whereas emotional func-
tioning and sexual functioning scored the lowest. In
addition, the most distressing symptom was fatigue,
followed by hair loss as the most intense symptom [26].
Similarly, in Jordan the social functioning scored the
highest and emotional functioning, body image and fu-
ture perspective scored the lowest. Hair loss cased the
worst symptom [28].
Factors associated with QOL
Studies conducted among Arab women with breast cancer
have identified socio-demographic and clinical factors as-
sociated with QOL. Results of studies conducted in UAE,
Yemen, Libanon and Bahrain have shown strong relation-
ship between clinical factors and QOL. As a result family
history of cancer, menopausal status, presence of metasta-
sis, time since diagnosis, symptoms, disease stage, pres-
ence of side effects and type of treatment received were
significantly associated with QOL [18, 22, 23, 26].
On the other hand, the studies conducted in Yemen,
Lebanon and Jordan have highlighted the association of
some sciodemographic factors and the QOL of pa-
tients[22, 23, 28]. Most factors identified in these studies
were monthly income, payments per month for medical
expenses andeducational status.
The study conducted in Tunisia showed a significant
deterioration in physical, cognitive and social function-
ing among patients undergoing treatment [20]. In Egypt,
the interventional study conducted by Mostapha et al.
revealed a significant change in physical, role, emotional,
cognitive and social functioning in pre-and post-
intervention assessment[21]. A strong relationship was
also found among Egyptian patients between QOL and
type of treatment, disease stage and presence of second-
aries [21].
The results of the two studies conducted in Yemen
[22, 25] were different regarding the relationship be-
tween age and QOL. The study conducted in 2011 con-
cluded the absence of this relationship [22] while the
second conducted in 2012 revealed that Younger women
(<50 years) showed significantly lower QOL scores than
older women (≥50 years) in all of the QOL subscales
[25].
Results of the qualitative study
The qualitative study conducted in Bahrain explored the
experiences of women who have survived breast cancer
and their perception of QOL after diagnosis. Global
QOL was expressed by participants in terms of being
able to perform every day chores and the ability to func-
tion in their daily role as a woman, wife, daughter and
employee. The study revealed the important role played
by the family and husband in treatment decisions and
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the importance of spirituality and religion to cope with
the disease [16].
Discussion
The objective of this study was to review published
research into QOL among Arab women with breast can-
cer; analyse the characteristics of these studies and the
main results reported. Our review paper focused only on
breast cancer and have included both qualitative and
quantitative papers.
In Arab countries, breast cancer accounts for 14 % to
42 % of all cancers in women. The physical, functional,
psychological and social problems that women live may
affect their quality of life. However, the results indicate
that research into the QOL of breast cancer patients is
poorly developed in Arab countries. After an extensive
literature review, we have identified only 13 articles that
met inclusion criteria. Despite the general recommenda-
tion to include QOL as an outcome in clinical studies
involving breast cancer patients [29].
The quantitative studies included in this review fo-
cused on the impact of breast cancer and its treatment
on QOL and analyzed the influence of socio demo-
graphic and clinical data [17, 19–26, 28]. While the
qualitative study conducted in Bahrain explored the ex-
periences, beliefs, perceptions and attitudes of women
with breast cancer towards their QOL [16].
This review of studies using EORTC C-30 question-
naire shows that the scores of QOL of Arabwomen with
breast cancer differ from country to country. Therefore
the mean scores of QOL varies from 45.3 to 74.6 on a
scale of 100 and good scores were recorded at UAE,
Tunisia, Bahrain and Jordan. The lowest mean score was
recorded among Kuwaiti Patients (45.3).
Nonetheless, we must be cautious in comparing data
from these studies. The literature using the EORTC
QLQ-C30 indicates that comparison of data should go
beyond the usual presentation of mean scores and sig-
nificant differences [30–33]. Disparity in QOL scores
among Arab women can be related to different inter-
pretation of QOL and selection bias. Indeed the popula-
tion under the study vary in terms of time since
diagnosis, disease stage, treatment received and the
questionnaire used might contributed to the observed
differences. For instance, studies conducted in Bahrain
and Jordan evaluated the QOL of breast cancer survi-
vors, while the researchers in UAE evaluated the QOL of
patients under treatment, and studies conducted in
Kuwait and Tunisia were carried out among patients
under chemotherapy. Moreover, the studies conducted
in Yemen and Egypt have used other types of question-
naires and thus the difficulty to compare their results
with the other studies remains.
Consistent with other international studies conducted
in Australia and Sweden [34, 35], the findings of our re-
view showed that breast cancer and its treatment affect
the QOL of patients in physical, psychological and social
domains. Among functional scales, high scores were re-
ported onsocial functioning in Kuwaiti, Lebanese, Bahraini
and Jordanian patients [19, 23, 26, 28]. Whereas the emo-
tional functioning scored the lowest in Jordanian and
Bahraini [26, 28]. Arab patients with breast cancer had
average to intense symptoms experience and intense level
of symptom experience was hair loss [19, 26, 28].
One of the reasons for having pooremotional function-
ing may be related to the fact that women with breast
cancer have to deal not only with the trauma of disfig-
urement but also with the fear of rejection by their part-
ners and loss of femininity [36]. They also are subjected
to too much pressure because of the burden of working
in different fields in addition to the commitments of
their roles as mothers and housewives.
The social domain had the highest scores among QOL
subscales. This may be referred to effective social sup-
port system in the Arab communitieswich plays an im-
portant role in reducing the pressure and improving
health. The experience of patients is usually influenced
by the spiritual and religious context characterized by
the solidarity and support. Many studies supported these
findings, Hebert et al. indicated that positive religious
coping methods predict better mental health and life sat-
isfaction in women with breast cancer [37].
In line with other research on QOL of breast cancer
[38–41], the findings of studies conducted among Arab
women have shown that clinical and socio demographic
factors were associated with QOL. The most clinical fac-
tors studied was the type of treatment. The triple modal-
ity of treatment predicted the worst QOL [17]. the
radiotherapy had significantly less effect compared to
chemotherapy [17, 22]. Patients who underwent mastec-
tomy reported lower levels of emotional, cognitive func-
tions, more side effects of treatment and arm symptoms
than patients who had undergone lumpectomy [18]. But
no difference was found between the patients who
underwent mastectomy with reconstruction and those
who had mastectomy alone [24].
Similar themes to other studies emerged in terms of im-
pact of socio demographic factors on QOL [39, 40]. The
most identified in our review were monthly income, pay-
ments per month for medical expenses and educational
status. This is supported by many studies which indicated
that increased QOL scores were significantly correlated
with increased education and better socioeconomics
status [22, 38, 40], [42–44]. In Denmark, Peuckmann and
his colleagues [45] reported that poor QOL was signifi-
cantly associated with short education. The same findings
were also reported by Esbensen and others [46] who
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showed that poor economy was associated with low QOL.
The family income was significantly influencing the over-
all QOL as reported by Pandey et al. [47]. The possible
justification for this findingsis the ability of the educated
women to understand the nature of the disease and to
comply with the therapeutic regime more than the unedu-
cated. Moreover, illiterate women with low income are
less likely to be screened for breast cancer, would delay
seeking care in the presence of symptoms and were diag-
nosed in later stages of the disease [22].
Although the results of other studies have shown the
relationship between age and the QOL of breast cancer
patients [39, 48]. Only the study by Sawsan Ba-Khubaira
et al. in Yemen has demonstrated this relationship among
Arab patients [25]. The findings for the association of age
with QOL are conflicting; some correlated poorer QOL
with increasing age [49, 50], while others found that youn-
ger age patients had more physical wellness and better
overall QOL [51]. The inconsistency of these studies may
be explained by differences in population background,
source of subjects and sample size.
The impact of socio demographic characteristics was far
different between Arab countries. This may be explained
by economic differences and health policy especially the
implementation of early detection and treatment pro-
grams of breast cancer.
Implications for practice and policy
The results highlight the need of a holistic care and the
importance of taking into consideration the cultural and
religious specificities in the treatment of Arab women
with breast cancer. Future research should test interven-
tion to assist Arab women to increase their personal opti-
mism, reduce symptom distress and enhance coping
strategies. The findings call for the institution of a psycho-
oncology services to address psycho-social outcomes.
Limitations of this review
Every effort was made to provide a comprehensive and
systematic review of the literature. However, it is pos-
sible that some studies may not have been captured in
the search and screening process and other did not meet
inclusion criteria [52–58] (Additional file 1). Also, the
difference of the base populations and the questionnaires
used to measure QOL does not allow a comparison of
QOL between Arab women. It is worth noting that the
majority of studies were cross-sectional and had a small
sample size and thus the findings could not be general-
ized to all Arab women with breast cancer.
Conclusion
This study investigated for the first time published re-
search on QOL among Arab women with breast cancer
even though insufficient information is available on
QOL in Arab women with breast cancer. Certainly, the
reviewer studies were very interesting and provided a
working basis for further studies. However, there is a
pressing need to support more research and publications
to improve QOL of Arab women with breast cancer in
Arab countries where the breast cancer incidence rates
have increased during recent years.
Additional file
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